Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases

Background. Infantile hemangiomas are revealed in 1-3% of newborns and 10-12% of infants. There are only anecdotal reports on the laser therapy efficacy in this pathology management. However, there is no common approach to the use of this method in the complex treatment of infantile hemangioma in infants. Clinical Cases Description. Two clinical cases of infantile hemangioma are presented. Patients underwent complex treatment: systemic propranolol and laser therapy via pulsed dye laser. Laser exposure modes ware selected individually: laser spot sizes were 10 and 12 mm, energy levels were 5-10 J/cm², burst duration was short (0.45 ms) or long (10-20 ms), procedure duration was from 15 to 40 minutes, number of procedures varied from 1 to 8. Laser therapy has shown its efficacy in treatment of superficial infantile hemangioma. Conclusion. The indication for using laser therapy in management of infants with hemangiomas is especially persistent residual signs such as telangiectasias and erythema after spontaneous or drug involution phase. Laser therapy allows us to avoid aggressive methods and improves the quality of life of our patients according to this article.

1. ISSVA classification for vascular anomalies. Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision, May, 2018. Available online: https://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf. Accessed on October 22, 2021.

2. Krowchuk DP, Frieden IJ, Mancini A.J. et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143(1):e20183475. doi: 10.1542/peds.2018-3475

3. Rotter A, de Oliveira ZNP. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. J Dtsch Dermatol Ges. 2017;15(12):1185-1190. doi: 10.1111/ddg.13365

4. Roginsky VV, Nadtochy AG, Grigorian AS. Diagnostics of formations from blood vessels at maxillofacial area and the neck of children. Pediatric dentistry and dental profilaxis. 2010;9(1):56-61. (In Russ).

5. Kotlukova NP, Belysheva TS, Valiev TT, et al. Interdisciplinary approach to the treatment of infant hemangioma. Pediatria. Journal n.a. G.N. Speransky. 2021;100(3):174-182. (In Russ). doi: 10.24110/0031-403X-2021-100-3-174-182

6. Johnson EF, Davis DM, Tollefson MM, et al. Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma. Am J Dermatopathol. 2018;40(4):231-239. doi: 10.1097/DAD.0000000000000983

7. Putra J, Al-Ibraheemi A. Vascular Anomalies of the Head and Neck: A Pediatric Overview. Head Neck Pathol. 2021;15(1):59-70. doi: 10.1007/s12105-020-01236-x

8. Briones M., Adams D. Neonatal Vascular Tumors. Clin Perinatol. 2021;48(1):181-198. doi: 10.1016/j.clp.2020.11.011

9. Satterfield KR, Chamber CB. Current treatment and management of infantile hemangiomas. Surv Opthalmol. 2019:64(5):608-618. doi: 10.1016/j.survophthal.2019.02.005

10. Tiemann L, Hein S. Infantile Hemangioma: A Review of Current Pharmacotherapy Treatment and Practice Pearls. J Pediatr Pharmacol Ther. 2020;25(7):586-599. doi: 10.5863/1551-6776-25.7.586

11. Harter N, Mancini AJ. Diagnosis and Management of Infantile Hemangiomas in the Neonate. Pediatr Clin North Am. 2019;66(2):437-459. doi: 10.1016/j.pcl.2018.12.011

12. Chen ZY, Wang QN, Zhu YH, et al. Progress in the treatment of infantile hemangioma. Ann Transl Med. 2019;7(22):692. doi: 10.21037/atm.2019.10.47

13. Adams DM, Ricci KW. Infantile Hemangiomas in the Head and Neck Region. Otolaryngol Clin North Am. 2018;51(1):77-87. doi: 10.1016/j.otc.2017.09.009

14. Ding Y, Zhang JZ, Yu SR, et al. Risk factors for infantile hemangioma: a meta-analysis. World J Pediatr. 2020;16(4):377-384. doi: 10.1007/s12519-019-00327-2

15. Kuzmichev PP, Yegorova ML, Shadrina IYe. Treatment of infantile hemangiomas. Zdravookhranenie Dal'nego Vostoka. 2020;1(83):86-89. (In Russ). doi: 10.33454/1728-1261-2020-1-86-89

16. Johnson CM, Navarro OM. Clinical and sonographic features of pediatric soft-tissue vascular anomalies part 1: classification, sonographic approach and vascular tumors. Pediatr Radiol. 2017;47(9):1184-1195. doi: 10.1007/s00247-017-3885-y

17. Moyakine AV, Herwegen B, van der Vleuten CJM. Use of the hemangioma severity scale to facilitate treatment decisions for infantile hemangiomas. J Am Acad Dermatol. 2017;77(5):868-873. doi: 10.1016/j.jaad.2017.06.003

18. Polyaev YA, Mylnikov AA, Garbuzov RV. Many years of experience in treatment of infantile hemangiomas in children. Pediatria. Journal n.a. G.N. Speransky. 2017;96(4):102-109. (In Russ). doi: 10.24110/0031-403X-2017-96-4-102-109

19. Sharafanovich EM, Konoplya NE, Averin VI. Medical treatment of infantile hemangiomas. Oncological Journal. 2019;13(1):103-109. (In Russ).

20. Belysheva TS, Moiseenko EI. Laser therapy of vascular birthmarks in children. Bone and soft tissue sarcomas, tumors of the skin. 2011;(3):37-48. (In Russ).

21. Trapeznikova TV, Pisklakova TP, Gubina VO. Objective methods selection of children with infantile hemangiomas for treatment by laser radiation and evaluation of effectiveness. RUDN Journal of Medicine. 2018;22(2):191-208. (In Russ). doi: 10.22363/2313-0245-2018-22-2-191-208

22. Shakina LD, Ponomarev IV, Smirnov IE. Laser surgery for skin vascular tumors in infants. Rossiyskiy Pediatricheskiy Zhurnal (Russian Pediatric Journal). 2019;22(2):99-105. (In Russ). doi: 10.18821/1560-9561-2019-22-2-99-105

23. Kotlukova NP, Konstantinova NK, Trunina II, et al. Sovremennaya strategiya i taktika vedeniya detei s mladencheskimi gemangiomami. Praktika pediatra. 2020;(4):4-12. (In Russ).

24. Hoeger PH, Harper JI, Baselga E, et al. Christine Leaute-Labreze1 Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr. 2015;174(7):855-865. doi: 10.1007/s00431-015-2570-0